Pubblicazioni

  • Home
  • Pubblicazioni
 
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Alemtuzumab significantly improves posterior fossa syndrome presented as a relapse of multiple sclerosis
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Baseline Patient and Caregiver Characteristics From a Prospective, Noninterventional, Real-World Study (REALITY) on the Effect of Alemtuzumab on Fatigue and Other Patient- and Caregiver-Reported Quality-of-Life Outcomes in Patients With RRMS
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Body mass Index influence CD20 dynamics in MS patients treated with Ocrelizumab
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Comparison of disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies Strategies for disease modification
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Disability assessment in the Google Maps era: a feasibility study to explore a new clinical opportunity
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Disease modifying treatment may delay time to wheelchair in primary progressive multiple sclerosis: a real-life cohort Pharmacological management of progressive MS
Giacomo Lus
Giacomo Lus
Vai all’articolo »